364 related articles for article (PubMed ID: 37946397)
1. Emerging clinical relevance of microbiome in cancer: promising biomarkers and therapeutic targets.
Dai JH; Tan XR; Qiao H; Liu N
Protein Cell; 2024 Apr; 15(4):239-260. PubMed ID: 37946397
[TBL] [Abstract][Full Text] [Related]
2. Complex interactions between the microbiome and cancer immune therapy.
Schwartz DJ; Rebeck ON; Dantas G
Crit Rev Clin Lab Sci; 2019 Dec; 56(8):567-585. PubMed ID: 31526274
[TBL] [Abstract][Full Text] [Related]
3. The human microbiome and cancer: a diagnostic and therapeutic perspective.
Kandalai S; Li H; Zhang N; Peng H; Zheng Q
Cancer Biol Ther; 2023 Dec; 24(1):2240084. PubMed ID: 37498047
[TBL] [Abstract][Full Text] [Related]
4. Role of the intratumoral microbiome in tumor progression and therapeutics implications.
Meng YF; Fan ZY; Zhou B; Zhan HX
Biochim Biophys Acta Rev Cancer; 2023 Nov; 1878(6):189014. PubMed ID: 37918451
[TBL] [Abstract][Full Text] [Related]
5. Gut microbiota: a potential target for improved cancer therapy.
Zhao M; Jiang G; Zhou H; Li J; Xiang W; Li S; Wang H; Zhou J
J Cancer Res Clin Oncol; 2023 Jan; 149(1):541-552. PubMed ID: 36550389
[TBL] [Abstract][Full Text] [Related]
6. Influence of Microbiota on Tumor Immunotherapy.
Yu X; Li W; Li Z; Wu Q; Sun S
Int J Biol Sci; 2024; 20(6):2264-2294. PubMed ID: 38617537
[TBL] [Abstract][Full Text] [Related]
7. Gut microbiota in cancer: insights on microbial metabolites and therapeutic strategies.
Chen Y; Wang X; Ye Y; Ren Q
Med Oncol; 2023 Dec; 41(1):25. PubMed ID: 38129370
[TBL] [Abstract][Full Text] [Related]
8. Role of the gut microbiota in anticancer therapy: from molecular mechanisms to clinical applications.
Zhao LY; Mei JX; Yu G; Lei L; Zhang WH; Liu K; Chen XL; Kołat D; Yang K; Hu JK
Signal Transduct Target Ther; 2023 May; 8(1):201. PubMed ID: 37179402
[TBL] [Abstract][Full Text] [Related]
9. The critical role of tumor microbiome in cancer immunotherapy.
Yang L; Wang Q; He L; Sun X
Cancer Biol Ther; 2024 Dec; 25(1):2301801. PubMed ID: 38241173
[TBL] [Abstract][Full Text] [Related]
10. Relevance of tumor microbiome in cancer incidence, prognosis, and its clinical implications in therapeutics.
Bahuguna A; Dubey SK
Biochim Biophys Acta Rev Cancer; 2023 Sep; 1878(5):188956. PubMed ID: 37473857
[TBL] [Abstract][Full Text] [Related]
11. Intratumor microbiota in cancer pathogenesis and immunity: from mechanisms of action to therapeutic opportunities.
Wang M; Yu F; Li P
Front Immunol; 2023; 14():1269054. PubMed ID: 37868956
[TBL] [Abstract][Full Text] [Related]
12. Microbiome and lung cancer: carcinogenic mechanisms, early cancer diagnosis, and promising microbial therapies.
Liu W; Pi Z; Wang X; Shang C; Song C; Wang R; He Z; Zhang X; Wan Y; Mao W
Crit Rev Oncol Hematol; 2024 Apr; 196():104322. PubMed ID: 38460928
[TBL] [Abstract][Full Text] [Related]
13. The Microbiome and Genitourinary Cancer: A Collaborative Review.
Markowski MC; Boorjian SA; Burton JP; Hahn NM; Ingersoll MA; Maleki Vareki S; Pal SK; Sfanos KS
Eur Urol; 2019 Apr; 75(4):637-646. PubMed ID: 30655087
[TBL] [Abstract][Full Text] [Related]
14. Intestinal Microbiota: A Novel Target to Improve Anti-Tumor Treatment?
Villéger R; Lopès A; Carrier G; Veziant J; Billard E; Barnich N; Gagnière J; Vazeille E; Bonnet M
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31533218
[TBL] [Abstract][Full Text] [Related]
15. Microbiota transplantation: Targeting cancer treatment.
Wu X; Zhang T; Chen X; Ji G; Zhang F
Cancer Lett; 2019 Jun; 452():144-151. PubMed ID: 30905818
[TBL] [Abstract][Full Text] [Related]
16. [Therapeutic Relevance of Human Microbiota and Lung Cancer].
Zhou H; Suo J; Zhu J
Zhongguo Fei Ai Za Zhi; 2019 Jul; 22(7):464-469. PubMed ID: 31315786
[TBL] [Abstract][Full Text] [Related]
17. The impact of tumor and gut microbiotas on cancer therapy: Beneficial or detrimental?
Hekmatshoar Y; Rahbar Saadat Y; Hosseiniyan Khatibi SM; Ozkan T; Zununi Vahed F; Nariman-Saleh-Fam Z; Pourghassem Gargari B; Sunguroglu A; Zununi Vahed S
Life Sci; 2019 Sep; 233():116680. PubMed ID: 31344431
[TBL] [Abstract][Full Text] [Related]
18. Understanding the microbiome: Emerging biomarkers for exploiting the microbiota for personalized medicine against cancer.
Rajpoot M; Sharma AK; Sharma A; Gupta GK
Semin Cancer Biol; 2018 Oct; 52(Pt 1):1-8. PubMed ID: 29425888
[TBL] [Abstract][Full Text] [Related]
19. The microbiome and precision oncology: an emerging paradigm in anticancer therapy.
Bhat SA; Kaur R; Chauhan A; Pal A
Crit Rev Microbiol; 2022 Nov; 48(6):770-783. PubMed ID: 35164642
[TBL] [Abstract][Full Text] [Related]
20. The Potential of the Gut Microbiome to Reshape the Cancer Therapy Paradigm: A Review.
Liu L; Shah K
JAMA Oncol; 2022 Jul; 8(7):1059-1067. PubMed ID: 35482355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
